Embecta Corp. (EMBC)
6.21
-0.06
(-0.96%)
USD |
NASDAQ |
Oct 19, 16:00
6.22
+0.01
(+0.16%)
After-Hours: 20:00
Embecta Profit Margin (Quarterly) : 7.77% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.77% |
| March 31, 2026 | -1.85% |
| December 31, 2025 | 16.88% |
| September 30, 2025 | 10.00% |
| June 30, 2025 | 15.40% |
| March 31, 2025 | 9.07% |
| December 31, 2024 | 0.00% |
| September 30, 2024 | 5.10% |
| June 30, 2024 | 5.39% |
| March 31, 2024 | 10.06% |
| December 31, 2023 | 7.25% |
| Date | Value |
|---|---|
| September 30, 2023 | 2.13% |
| June 30, 2023 | 5.31% |
| March 31, 2023 | 5.05% |
| December 31, 2022 | 12.77% |
| September 30, 2022 | -6.26% |
| June 30, 2022 | 21.44% |
| March 31, 2022 | 29.00% |
| December 31, 2021 | 34.15% |
| September 30, 2021 | 32.31% |
| June 30, 2021 | 35.49% |
| March 31, 2021 | 37.97% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Artivion, Inc. | -10.73% |
| Abbott Laboratories | 7.37% |
| AngioDynamics, Inc. | -8.77% |
| Alphatec Holdings, Inc. | -12.07% |
| AtriCure, Inc. | 5.83% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 7.77% |
| Return on Invested Capital | 10.73% |
| Gross Profit Margin (Quarterly) | 55.47% |
| Operating Margin (Quarterly) | 23.67% |
| Return on Net Operating Assets | 12.95% |